These results clearly demonstrate specific up-regulation of TCII and TCII-R expression by proliferating malignant tissues across multiple tumor types in both canine and feline species, and provide compelling support for use of TCII and TCII-R proteins as cancer biomarkers, as well as the use of Cbl-bound diagnostic and therapeutic agents in clinical cancer medicine. This evidence concerns the gene CBL and cancer.